Amgen, DxS, Lab21 sales and marketing update

Lab21 will provide a screening service in the U.K. using DxS's K-RAS Mutation Detection Kit to determine which advanced bowel cancer patients are likely to benefit from Amgen's Vectibix panitumumab....